Testing effectiveness (Phase 2)Looking for participantsNCT07103746
What this trial is testing
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Who this might be right for
Autoimmune Disorders
National Institute of Allergy and Infectious Diseases (NIAID) 30